The commissioning of the plant’s first production line signals the full-scale ... achieving an average cycle time (CT) of 0.75 seconds per cell—20% faster than traditional industry standards.

“Will the cycle eventually catch up to patients who have gone through CAR T-cell therapy? Does innate immune dysfunction disappear with CAR T or BiTE? Interferon responses and long-term ...

and a score on the basis of the Oncotype DX CC Recurrence Score using the same formula from the stromal score and the cell cycle score. The Immune Proliferative Stromal (IPS) score was defined as the ...

The research also combined advanced sequencing techniques to explore the interplay between genetic mutations, cell cycle dynamics, and cancer evolution, providing insights into metastatic potential.

Kepler's sun drawings are the oldest sunspot records with known dates. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. "Half-forgotten ...

"Half-forgotten" sunspot drawings by Renaissance astronomer Johannes Kepler are showing us more about how the sun's cycle of activities work. Kepler (1571-1630), who was born in what we now call ...

Ask the publishers to restore access to 500,000+ books. An icon used to represent a menu that can be toggled by interacting with this icon. A line drawing of the Internet Archive headquarters building ...

With so much at stake, nature keeps it tightly controlled in a process called the cell cycle that scientists thought they thoroughly understood. But now it turns out there was more to know. Scientists ...

The vertical dashed line represents the multimodal treatment threshold at CCR = 2.112. The x-axis shows the range of CCR scores observed in 99% of clinically tested patients. ADT, androgen-deprivation ...

In this phase 2 trial, we aimed to evaluate the efficacy and safety of adebrelimab plus chemotherapy and sequential TRT as first-line therapy ... 1 Flow diagram of the trial. FFPE, formalin-fixed ...

In this interview, Dr. Tabitha Bullock, a principal group leader at Lonza, tells us about some of the key considerations in cell line development and how advances in technology are improving the ...